Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

MILabs Introduces New Benchtop Product Line

Press releases may be edited for formatting or style | May 06, 2013
Utrecht, The Netherlands -- MILabs, B.V. the Netherlands-based innovator and manufacturer of pre-clinical SPECT/PET/CT imaging devices used in biomedical research, today announces the release of the new mini product family - an easy-to-use series of benchtop SPECT and PET imagers for small animals that combine simplified workflow, compact dimensions and affordable pricing to bring high-performance SPECT/PET within everyone's reach.

MILabs' mini is a new product family developed for researchers with limited lab space or research budgets, as solutions for high quality SPECT and/or PET imaging. The mini product family consists of three different platforms: the U-SPECT mini , the U-PET mini and the VECTor mini combining the best aspects from both SPECT and PET as well as advanced simultaneous SPECT/PET imaging, in a unique benchtop configuration. Moreover, even with these compact dimensions, the mini systems come with the same benefits that the world-wide users of MILabs high-performance U-SPECT and VECTor systems get to enjoy: unmatched high resolution, list-mode acquisitions, fast dynamic modes, high precision reconstruction algorithms and multi-modality connectivity. In addition, the MILabs mini systems also offer streamlined workflow and user friendliness with simplified installation and attractive pricing, thereby effectively bridging the long-existing gap between performance and price in preclinical imaging. A new history is written with the mini family by expanding the horizon of MILabs' tradition in providing high-end technologies with unmatched performance to include highly attractive pricing as an additional attribute.


stats
DOTmed text ad

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.

stats

About MILabs B.V.
MILabs provides high-end pre-clinical molecular imaging solutions (SPECT/PET/CT) for biomedical and pharmaceutical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as cancer, cardiac and neurodegenerative diseases, depression and diabetes.
www.milabs.com

You Must Be Logged In To Post A Comment